Nuwellis Expands Pediatric Footprint with Aquadex SmartFlow Installations in Michigan
Event summary
- Nuwellis installed three Aquadex SmartFlow systems at a leading pediatric healthcare provider in Michigan, marking its first pediatric program in the state.
- The installations aim to develop clinical protocols and workflows for integrating Aquadex therapy into pediatric care.
- Nuwellis recently completed a pre-submission meeting with the FDA to discuss expanding the Aquadex label to support pediatric patients weighing 5 kilograms and above.
The big picture
Nuwellis’ move into Michigan’s pediatric market aligns with a broader industry trend of expanding advanced fluid management solutions into critical care settings. The company’s focus on pediatric patients underscores the strategic importance of untapped markets, particularly as clinicians increasingly recognize the benefits of precise ultrafiltration therapy for fluid overload in critically ill children.
What we're watching
- Market Expansion
- How Nuwellis will leverage this entry into Michigan’s pediatric market to drive broader adoption of Aquadex therapy.
- Regulatory Progress
- Whether the FDA’s response to Nuwellis’ pre-submission meeting will accelerate label expansion for younger pediatric patients.
- Clinical Integration
- The pace at which Nuwellis can establish standardized protocols and workflows in pediatric care settings.
Related topics